Summary of the published data and standardized mean differences (SMDs; Hedge’s g) of DLQI measured prior to and after the commencement of infliximab, adalimumab, ixekizumab, secukinumab and tofacitinib plaque psoriasis patients.
收藏NIAID Data Ecosystem2026-03-12 收录
下载链接：
https://figshare.com/articles/dataset/Summary_of_the_published_data_and_standardized_mean_differences_SMDs_Hedge_s_g_of_DLQI_measured_prior_to_and_after_the_commencement_of_infliximab_adalimumab_ixekizumab_secukinumab_and_tofacitinib_plaque_psoriasis_patients_/13327899
下载链接
链接失效反馈官方服务：
资源简介：
Summary of the published data and standardized mean differences (SMDs; Hedge’s g) of DLQI measured prior to and after the commencement of infliximab, adalimumab, ixekizumab, secukinumab and tofacitinib plaque psoriasis patients.
创建时间：
2020-12-03
